Koers The Flowr Corporation Toronto S.E.
Aandelen
FLWR.H
CA34354X1087
Farmaceutische producten
Omzet 2020 | 7,51 10,29 7,02 | Omzet 2021 | 12,35 16,92 11,54 | Marktkapitalisatie | 22,37 mln. 30,65 mln. 20,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -126 mln. -173 mln. -118 mln. | Nettowinst (verlies) 2021 | -85 mln. -116 mln. -79,45 mln. | EV/omzet 2020 | 16.546.858 x |
Nettoschuld 2020 | 29,2 mln. 40,01 mln. 27,29 mln. | Nettoschuld 2021 | 17,1 mln. 23,43 mln. 15,98 mln. | EV/omzet 2021 | 3.196.178 x |
K/w-verhouding 2020 |
-0,35
x | K/w-verhouding 2021 |
-0,24
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 65,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,18 mld. | |
+3,98% | 3,16 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |